NCT06359132Completed
mHealth Rhythm Management in Terms of Cancelling Unnecessary Scheduled ECVs in Presumed Persistent AFpatients.
The Effect of Integrated Mobile Health-supported Heart Rhythm Management Around Electrical Cardioversion in Terms of Cancelling Unnecessary Scheduled ECV Appointments in Patients With Presumed Persistent Atrial Fibrillation (TeleConvert-AF)
Source: ClinicalTrials.gov · Last updated 13 Oct 2026
Brief summary (registry, in English)
Despite a clear definition in the European Society of Cardiology (ESC) guidelines, the differentiation between paroxysmal (self-terminating) and persistent (nonself- terminating) atrial fibrillation (AF) remains challenging in clinical practice. Some patients with presumed persistent AF are planned for electrical cardioversion (ECV) but appear to have a paroxysmal pattern or present in sinus rhythm (SR) at the scheduled ECV appointment. This results in unnecessary visits or interventions for patients, and costs and burden for the hospitals and health insurances. Based on the feasibility of the TeleCheck-AF approach, which is an on-demand mobile health (mHealth) infrastructure incorporating app-based heart rate and rhythm monitoring to support remote AF management through teleconsultation, the investigators aim to extend this mHealth approach to the management of presumed persistent AF patients planned for ECV.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 270 (actual)
- First submitted
- 9 Jan 2024
- Start date
- 1 Jul 2022
- Primary completion date
- 1 Jun 2025
- Lead sponsor
- Maastricht University Medical Center
- Diseases
- Atrial fibrillation
- NCT number
- NCT06359132
What you commit to
- Study type: Observational
- Participants enrolled: 270
- From 1 Jul 2022 to the primary completion date, 1 Jun 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of an active implanted electronic cardiac device
Other
- Deemed unsuitable for participation by attending physician
Who the study is looking for
- Presumed persistent AF
- Scheduled for ECV
- Age ≥18 years
- Smartphone possession
- Ability and willing to sign informed consent
- Ability and willing to use mobile phone app (FibriCheck)
Age in the registry: 18 years to - · Sex: All
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Maastricht University Medical Center Coordinator of this site? Confirm its status | Maastricht | Netherlands | Unknown status |
| VieCuri Medical Center Coordinator of this site? Confirm its status | Venlo | Netherlands | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.